Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura M Yates

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Drug Safety|July 7, 2025
Temporal Changes in Reporting of Neurodevelopmental Outcomes After Maternal Exposure to Valproate: A Contribution of the ConcePTION ProjectDimitra Gkolfi, Yrea R J van Rijt-Weetink, Henric Taavola-Gustafsson, et al.
Epilepsia|July 5, 2023
Neurodevelopment of babies born to mothers with epilepsy: A prospective observational cohort studyRebecca L Bromley, Philip Bullen, Ellen Campbell, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2026
Copy Number Variant analysis by exome sequencing is an effective approach to optimize diagnostic yield for developmental disorders - the DDD-Africa studyNadja Louw, Prince Makay, Phelelani T Mpangase, et al.
Epilepsia|May 22, 2024
The use of parent-completed questionnaires to investigate developmental outcomes in large populations of children exposed to antiseizure medications in pregnancyMatthew Bluett-Duncan, Philip Bullen, Ellen Campbell, et al.
Neurology|May 20, 2016
Pregnancy outcome following maternal exposure to pregabalin may call for concernUrsula Winterfeld, Paul Merlob, David Baud, et al.
British Journal of Clinical Pharmacology|May 29, 2026
Characteristics and temporal trends of EU teratological safety signals and information dissemination to healthcare professionals in the Netherlands-A contribution of the ConcePTION projectYrea R J van Rijt-Weetink, Rosanne E Huisman, Jan-Peter van Wieringen, et al.
Drug Safety|March 28, 2023
Core Data Elements for Pregnancy Pharmacovigilance Studies Using Primary Source Data Collection Methods: Recommendations from the IMI ConcePTION ProjectJonathan L Richardson, Alan Moore, Rebecca L Bromley, et al.
American Journal of Medical Genetics. Part A|February 18, 2020
Nine newly identified individuals refine the phenotype associated with MYT1L mutationsIsabelle C Windheuser, Jessica Becker, Kirsten Cremer, et al.
Drug Safety|February 5, 2025
Delphi Method Consensus on Statistical Analysis and Reporting Recommendations for Single-Arm Pregnancy Medication Safety Studies Investigating Pregnancy, Birth and Neonatal Health Outcomes: A Contribution from IMI-ConcePTIONJonathan L Richardson, Alan Moore, Michael Stellfeld, et al.
Journal of Psychopharmacology (Oxford, England)|April 26, 2017
British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017R Hamish McAllister-Williams, David S Baldwin, Roch Cantwell, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Drug Safety|July 7, 2025
Temporal Changes in Reporting of Neurodevelopmental Outcomes After Maternal Exposure to Valproate: A Contribution of the ConcePTION ProjectDimitra Gkolfi, Yrea R J van Rijt-Weetink, Henric Taavola-Gustafsson, et al.
Epilepsia|July 5, 2023
Neurodevelopment of babies born to mothers with epilepsy: A prospective observational cohort studyRebecca L Bromley, Philip Bullen, Ellen Campbell, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2026
Copy Number Variant analysis by exome sequencing is an effective approach to optimize diagnostic yield for developmental disorders - the DDD-Africa studyNadja Louw, Prince Makay, Phelelani T Mpangase, et al.
Epilepsia|May 22, 2024
The use of parent-completed questionnaires to investigate developmental outcomes in large populations of children exposed to antiseizure medications in pregnancyMatthew Bluett-Duncan, Philip Bullen, Ellen Campbell, et al.
Neurology|May 20, 2016
Pregnancy outcome following maternal exposure to pregabalin may call for concernUrsula Winterfeld, Paul Merlob, David Baud, et al.
British Journal of Clinical Pharmacology|May 29, 2026
Characteristics and temporal trends of EU teratological safety signals and information dissemination to healthcare professionals in the Netherlands-A contribution of the ConcePTION projectYrea R J van Rijt-Weetink, Rosanne E Huisman, Jan-Peter van Wieringen, et al.
Drug Safety|March 28, 2023
Core Data Elements for Pregnancy Pharmacovigilance Studies Using Primary Source Data Collection Methods: Recommendations from the IMI ConcePTION ProjectJonathan L Richardson, Alan Moore, Rebecca L Bromley, et al.
American Journal of Medical Genetics. Part A|February 18, 2020
Nine newly identified individuals refine the phenotype associated with MYT1L mutationsIsabelle C Windheuser, Jessica Becker, Kirsten Cremer, et al.
Drug Safety|February 5, 2025
Delphi Method Consensus on Statistical Analysis and Reporting Recommendations for Single-Arm Pregnancy Medication Safety Studies Investigating Pregnancy, Birth and Neonatal Health Outcomes: A Contribution from IMI-ConcePTIONJonathan L Richardson, Alan Moore, Michael Stellfeld, et al.
Journal of Psychopharmacology (Oxford, England)|April 26, 2017
British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017R Hamish McAllister-Williams, David S Baldwin, Roch Cantwell, et al.
Pageof 3